Assistant Professor, Medicine, Oregon Health and Science University School of Medicine
Hematology
Dr. Kevin W. Yee, MD
|
|
Give Review
Kevin is an expert in the field of Hematology. He researched medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Kevin is a published doctor. He published 9 publications, including: 'A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with com...' Kevin W. Yee is registered with Medicare.
Publications
- A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory Acute myeloid leukemia: inhibition of Akt activation correlates with com...
- The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin.
- A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with Acute myeloid leukemia aged 60 year...
- FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248).
- Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells.
- Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970.
- SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo.
- SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase.
Schools
D Geffen Sch Of MedUcla
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
University of California Irvine -
David Geffen School of Medicine at UCLA
Hospital
-
Providence Portland Medical Center -
Providence St. Vincent Medical Center
Drug Facts
| NPI NUMBER | 1548263189 | |
| NPPES Provider LastName | YEE | |
| NPPES Provider FirstName | KEVIN | |
| NPPES Provider ZIPCode | 970060000 | |
| NPPES Provider State | OR | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1150.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 223.0 | |
| Percent Opioid Claims | 19.39 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548263189 |
| Last Name Of The Provider | YEE |
| First Name Of The Provider | KEVIN |
| View All |
Similar Doctors
|
|
Dr. Katharine L. Barford, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary W. Takahashi, MD
This Doctor is OpenDoctor Recommended.
|